Value of lactate level in predicting the short-term prognosis of patients with acute-on-chronic hepatitis B liver failure

Shuo YANG; Kun LIU; Lan YANG; Ling XU; Xiaobo LU; Xiaofeng SUN; MALIPATI Elkenjiang

doi:10.3969/j.issn.1001-5256.2022.07.007

Volume 38 Issue 7

Jul. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(7): 1482-1488

PDF( 2603 KB)

Value of lactate level in predicting the short-term prognosis of patients with acute-on-chronic hepatitis B liver failure

DOI: 10.3969/j.issn.1001-5256.2022.07.007

Shuo YANG^1a,
Kun LIU^1b,
Lan YANG^1b,
Ling XU^1b,
Xiaobo LU^{1a, 2},
Xiaofeng SUN^{1a, 2
,
,
,},
MALIPATI Elkenjiang^1b

1a.
Center for Infectious Diseases-Hepatology of The First Affiliated Hospital, Xinjiang Medical University, Urumqi 830000, China
1b.
The First Clinical Medical College, Xinjiang Medical University, Urumqi 830000, China
2.
Xinjiang Clinical Medical Research Center for Infectious Diseases (Viral Hepatitis), Urumqi 830000, China

Research funding:

National Natural Science Foundation of China (82060115)

More Information

Corresponding author: SUN Xiaofeng, xjwlsxf@163.com(ORCID: 0000-0002-2596-3669)
Received Date: 2021-12-06
Accepted Date: 2022-01-22
Published Date: 2022-07-20

Abstract

Abstract

Objective To investigate the value of lactate in predicting the 90-day prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). Methods A retrospective analysis was performed for 117 patients with HBV-ACLF who were admitted to Center for Infectious Diseases-Hepatology, The First Affiliated Hospital of Xinjiang Medical University, from January 2017 to June 2021, and according to the results of 90-day follow-up, they were divided into survival group with 43 patients and death group with 74 patients. Related clinical data were collected, including routine blood test results, hepatic and renal function, coagulation function, arterial blood gas parameters, and complications such as hepatic encephalopathy within 24 hours after the diagnosis of HBV-ACLF in our hospital, and albumin-bilirubin (ALBI), Model for End-Stage Liver Disease (MELD), MELD combined with serum sodium concentration (MELD-Na), MELD to SNa ratio (MESO), integrated MELD (iMELD), and CLIF-C ACLF scores were calculated. The t-test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. A binary logistic regression analysis was used to investigate whether lactate was an independent risk factor for the 90-d prognosis of HBV-ACLF patients, and a Pearson correlation analysis was used to investigate the correlation of lactate with infection and clinical complications. The receiver operating characteristic (ROC) curve was plotted to analyze whether lactate, in combination with each score, can improve the predictive value of the existing model, and the Z test was used for pairwise comparison. Results Compared with the survival group, the death group had significantly higher white blood cell count, international normalized ratio (INR), and lactate and a significantly lower level of Na (Z=-2.813, -2.855, and -3.186, and -2.044, all P < 0.05), as well as significantly higher age and MELD, MELD-Na, MESO, iMELD, and CLIF-C ACLF scores (t=2.536, 4.615, 4.247, 4.941, 5.832, and 7.562, all P < 0.05). The logistic regression analysis showed that age (odds ratio [OR]=1.075, 95% confidence interval [CI]: 1.026-1.127, P=0.002), INR (OR=2.198, 95%CI: 1.149-4.203, P=0.017), and lactate (OR=1.431, 95%CI: 1.002-2.044, P=0.049) were independent risk factors for the 90-day prognosis of patients with HBV-ACLF, and there was an increase in the area under the ROC curve after lactate was included in the existing models. Conclusion Lactate is an independent risk factor for the 90-day prognosis of patients with HBV-ACLF, and its inclusion in existing models may improve predictive value.
- Acute-on-Chronic Liver Failure,
- Hepatitis B virus,
- Lactic Acid,
- Prognosis

FullText(HTML)

References(38)

References

[1]	BERNAL W, JALAN R, QUAGLIA A, et al. Acute-on-chronic liver failure[J]. Lancet, 2015, 386(10003): 1576-1587. DOI: 10.1016/S0140-6736(15)00309-8.
[2]	LIAW YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia[J]. J Hepatol, 2009, 51(2): 403-410. DOI: 10.1016/j.jhep.2009.04.003.
[3]	SHEN Y, WANG X, ZHANG S, et al. A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics[J]. Sci Rep, 2016, 6: 33389. DOI: 10.1038/srep33389.
[4]	CHEN W, YOU J, CHEN J, et al. Combining the serum lactic acid level and the lactate clearance rate into the CLIF-SOFA score for evaluating the short-term prognosis of HBV-related ACLF patients[J]. Expert Rev Gastroenterol Hepatol, 2020, 14(6): 483-489. DOI: 10.1080/17474124.2020.1763172.
[5]	CHEN W, YOU J, CHEN J, et al. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. World J Gastroenterol, 2017, 23(40): 7303-7309. DOI: 10.3748/wjg.v23.i40.7303.
[6]	van HALL G. Lactate kinetics in human tissues at rest and during exercise[J]. Acta Physiol(Oxf), 2010, 199(4): 499-508. DOI: 10.1111/j.1748-1716.2010.02122.x.
[7]	NIE Y, ZHANG Y, LIU LX, et al. Serum lactate level predicts short-term and long-term mortality of HBV-ACLF patients: a prospective study[J]. Ther Clin Risk Manag, 2020, 16: 849-860. DOI: 10.2147/TCRM.S272463.
[8]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[9]	JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33(6): 550-558. DOI: 10.1200/JCO.2014.57.9151.
[10]	KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. DOI: 10.1053/jhep.2001.22172.
[11]	BIGGINS SW, KIM WR, TERRAULT NA, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660. DOI: 10.1053/j.gastro.2006.02.010.
[12]	HUO TI, WANG YW, YANG YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis[J]. Liver Int, 2007, 27(4): 498-506. DOI: 10.1111/j.1478-3231.2007.01445.x.
[13]	LUCA A, ANGERMAYR B, BERTOLINI G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J]. Liver Transpl, 2007, 13(8): 1174-1180. DOI: 10.1002/lt.21197.
[14]	HERNAEZ R, SOLÀ E, MOREAU R, et al. Acute-on-chronic liver failure: an update[J]. Gut, 2017, 66(3): 541-553. DOI: 10.1136/gutjnl-2016-312670.
[15]	REN Y, LIU L, LI Y, et al. Development and validation of a scoring system to predict progression to acute-on-chronic liver failure in patients with acute exacerbation of chronic hepatitis B[J]. Hepatol Res, 2018, 48(9): 692-700. DOI: 10.1111/hepr.13062.
[16]	ZHANG WJ, ZHANG LJ, WU JZ. Value of MELD、AARC、COSSH ccoring systems in evaluating the 90 -day prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2020, 36(4): 813-817. DOI: 10.3969/j.issn.1001-5256.2020.04.021. 张文佳, 赵丽娟, 吴基洲. MELD、AARC、COSSH评分系统对乙型肝炎相关慢加急性肝衰竭90天预后的评估价值[J]. 临床肝胆病杂志, 2020, 36(4): 813-817. DOI: 10.3969/j.issn.1001-5256.2020.04.021.
[17]	DU Q, LU SJ, LU DX, et al. Clinical characteristics and prognosis of patients with decompensated liver cirrhosis complicated with chronic and acute liver failure[J]. Chin J Gerontol, 2021, 41(3): 520-523. DOI: 10.3969/j.issn.1005-9202.2021.03.021. 杜蔷, 陆盛菊, 卢大秀, 等. HBV感染失代偿期肝硬化并发慢加急性肝衰竭患者的临床特点及预后[J]. 中国老年学杂志, 2021, 41(3): 520-523. DOI: 10.3969/j.issn.1005-9202.2021.03.021.
[18]	SHANG DB, XIANG XG. Advances in the pathogenesis and treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(4): 765-769. DOI: 10.3969/j.issn.1001-5256.2021.04.005. 尚大宝, 项晓刚. 慢加急性肝衰竭的发病机制和治疗进展[J]. 临床肝胆病杂志, 2021, 37(4): 765-769. DOI: 10.3969/j.issn.1001-5256.2021.04.005.
[19]	KRAUT JA, MADIAS NE. Lactic acidosis[J]. N Engl J Med, 2014, 371(24): 2309-2319. DOI: 10.1056/NEJMra1309483.
[20]	HILL AV. Muscular activity and carbohydrate metabolism[J]. Science, 1924, 60(1562): 505-514. DOI: 10.1126/science.60.1562.505.
[21]	BROOKS GA. The science and translation of lactate shuttle theory[J]. Cell Metab, 2018, 27(4): 757-785. DOI: 10.1016/j.cmet.2018.03.008.
[22]	CARDOSO FS, ABRALDES JG, SY E, et al. Lactate and number of organ failures predict intensive care unit mortality in patients with acute-on-chronic liver failure[J]. Liver Int, 2019, 39(7): 1271-1280. DOI: 10.1111/liv.14083.
[23]	KRUSE JA, ZAIDI SA, CARLSON RW. Significance of blood lactate levels in critically ill patients with liver disease[J]. Am J Med, 1987, 83(1): 77-82. DOI: 10.1016/0002-9343(87)90500-6.
[24]	JEPPESEN JB, MORTENSEN C, BENDTSEN F, et al. Lactate metabolism in chronic liver disease[J]. Scand J Clin Lab Invest, 2013, 73(4): 293-299. DOI: 10.3109/00365513.2013.773591.
[25]	DROLZ A, HORVATITS T, RUTTER K, et al. Lactate improves prediction of short-term mortality in critically ill patients with cirrhosis: a multinational study[J]. Hepatology, 2019, 69(1): 258-269. DOI: 10.1002/hep.30151.
[26]	CHAMULEAU RA. Bioartificial liver support anno 2001[J]. Metab Brain Dis, 2002, 17(4): 485-491. DOI: 10.1023/a:1021990725508.
[27]	TRIANTAFYLLOU E, WOOLLARD KJ, MCPHAIL M, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure[J]. Front Immunol, 2018, 9: 2948. DOI: 10.3389/fimmu.2018.02948.
[28]	ZHANG DJ, ZHOU B, HOU JL. Research progress in prognostic models of acute-on-chronic liver failure[J]. J Clini Hepatol, 2018, 34(6): 1351-1356. DOI: 10.3969/j.issn.1001-5256.2018.06.047. 张东敬, 周彬, 侯金林. 慢加急性肝衰竭预后模型的研究进展[J]. 临床肝胆病杂志, 2018, 34(6): 1351-1356. DOI: 10.3969/j.issn.1001-5256.2018.06.047.
[29]	LI H, ZHENG J, CHEN L, et al. The scoring systems in predicting short-term outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Ann Palliat Med, 2020, 9(5): 3048-3058. DOI: 10.21037/apm-20-608.
[30]	WILLIAMS MA, BEVAN MJ. Effector and memory CTL differentiation[J]. Annu Rev Immunol, 2007, 25: 171-192. DOI: 10.1146/annurev.immunol.25.022106.141548.
[31]	WHERRY EJ, AHMED R. Memory CD8 T-cell differentiation during viral infection[J]. J Virol, 2004, 78(11): 5535-5545. DOI: 10.1128/JVI.78.11.5535-5545.2004.
[32]	MICHALEK RD, RATHMELL JC. The metabolic life and times of a T-cell[J]. Immunol Rev, 2010, 236: 190-202. DOI: 10.1111/j.1600-065X.2010.00911.x.
[33]	JACOBS SR, HERMAN CE, MACIVER NJ, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways[J]. J Immunol, 2008, 180(7): 4476-4486. DOI: 10.4049/jimmunol.180.7.4476.
[34]	RATHMELL JC, ELSTROM RL, CINALLI RM, et al. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma[J]. Eur J Immunol, 2003, 33(8): 2223-2232. DOI: 10.1002/eji.200324048.
[35]	VELLINGA N, BOERMA EC, KOOPMANS M, et al. Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis[J]. Crit Care, 2017, 21(1): 255. DOI: 10.1186/s13054-017-1842-7.
[36]	BAKKER J, NIJSTEN MW, JANSEN TC. Clinical use of lactate monitoring in critically ill patients[J]. Ann Intensive Care, 2013, 3(1): 12. DOI: 10.1186/2110-5820-3-12.
[37]	JEPPESEN JB, MORTENSEN C, BENDTSEN F, et al. Lactate metabolism in chronic liver disease[J]. Scand J Clin Lab Invest, 2013, 73(4): 293-299. DOI: 10.3109/00365513.2013.773591.
[38]	BOSOI CR, ROSE CF. Elevated cerebral lactate: Implications in the pathogenesis of hepatic encephalopathy[J]. Metab Brain Dis, 2014, 29(4): 919-925. DOI: 10.1007/s11011-014-9573-9.

Relative Articles

[1]	Jiongjiong BI, Yingjie MA. Characteristics of the composition of intestinal flora in cirrhotic patients with malnutrition[J]. Journal of Clinical Hepatology, 2024, 40(1): 83-88. doi: 10.12449/JCH240115
[2]	Nan GENG, Ming KONG, Yu CHEN, Zhongping DUAN. Association between portal hypertension and malnutrition in liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(9): 2205-2209. doi: 10.3969/j.issn.1001-5256.2023.09.026
[3]	Honglin MA, Jing YANG, Qiu JIN, Run LUO, Jiao LENG, Xia WANG. Current status of research on nutritional support in end-stage liver disease[J]. Journal of Clinical Hepatology, 2022, 38(1): 215-219. doi: 10.3969/j.issn.1001-5256.2022.01.038
[4]	Yumei HE, Liping WU, Zhiming WANG, Menghao HAO, Ling HU, Jiazhen LI, Xiaobin SUN. Research progress in nutritional support for liver cirrhosis patients[J]. Journal of Clinical Hepatology, 2022, 38(12): 2846-2849. doi: 10.3969/j.issn.1001-5256.2022.12.031
[5]	Yijun ZHANG, Qian ZHANG, Xinhua LUO. Assessment and clinical management of malnutrition and asthenia in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1646-1649. doi: 10.3969/j.issn.1001-5256.2022.07.035
[6]	Chinese Society of Nutritional Oncology, Chinese Society for Parenteral and Enteral Nutrition. Expert opinion on nutritional treatment for patients with biliary tract tumors[J]. Journal of Clinical Hepatology, 2021, 37(9): 2058-2061. doi: 10.3969/j.issn.1001-5256.2021.09.011
[7]	Bo GAO, Yuzheng ZHUGE. Malnutrition in liver cirrhosis: Benefits from improving portal hypertension[J]. Journal of Clinical Hepatology, 2021, 37(12): 2767-2769. doi: 10.3969/j.issn.1001-5256.2021.12.005
[8]	Dandan JIA, Guiying ZHU, Shiyao LIAO, Hui ZHANG, Hui GUO, Lili YANG, Changmiao WANG. Interpretation of European Society for Clinical Nutrition and Metabolism practical guideline : Clinical nutrition in liver disease (2020)[J]. Journal of Clinical Hepatology, 2021, 37(7): 1553-1557. doi: 10.3969/j.issn.1001-5256.2021.07.015
[9]	Xiaoting SONG, Wentao XU, Yu CHEN, Xingshun QI. An excerpt of malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases[J]. Journal of Clinical Hepatology, 2021, 37(12): 2787-2789. doi: 10.3969/j.issn.1001-5256.2021.12.011
[10]	Huijuan XIAO, Tao HAN. Prevention and treatment of malnutrition, sarcopenia, and osteoporosis in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 26-30. doi: 10.3969/j.issn.1001-5256.2021.01.006
[11]	Xiao HuiJuan, Qi YuMei, Han Tao. An excerpt of ESPEN guideline on clinical nutrition in liver disease (2019)[J]. Journal of Clinical Hepatology, 2019, 35(5): 968-972. doi: 10.3969/j.issn.1001-5256.2019.05.007
[12]	Ma Bao, Deng Yong, Wang ZhiXin, Wang HaiJiu, Fan HaiNing. A preliminary study of the pathogenesis of malnutrition in patients with hepatic alveolar echinococcosis[J]. Journal of Clinical Hepatology, 2018, 34(1): 204-206. doi: 10.3969/j.issn.1001-5256.2018.01.045
[13]	Zhu BingHua, Zhao ZhangQing, Zhou Yang, Xu LieMing. A nutritional risk screening model for patients with liver cirrhosis established using discriminant analysis[J]. Journal of Clinical Hepatology, 2017, 33(6): 1106-1111. doi: 10.3969/j.issn.1001-5256.2017.06.018
[14]	Zhu Bin, Zou CongCong, Zheng Xin. Malnutrition assessment and nutrition support therapy for end-stage liver disease[J]. Journal of Clinical Hepatology, 2017, 33(9): 1699-1706. doi: 10.3969/j.issn.1001-5256.2017.09.014
[15]	Gan XueMei, Li Wu. Nutrition support therapy for patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2016, 32(1): 178-181. doi: 10.3969/j.issn.1001-5256.2016.01.039
[16]	Zhang HuiKai, Meng XiangLin, Li HaiLei, Xu YuLing, Luo HongWei. Current status of malnutrition and its association with prognosis in hospitalized patients with decompensated liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1100-1103. doi: 10.3969/j.issn.1001-5256.2016.06.015
[17]	Zhang Jian. Correlation between malnutrition and prognosis of hepatitis A in Uygur children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1235-1237. doi: 10.3969/j.issn.1001-5256.2015.08.013
[18]	Zhang Min, Hang Lei, Yuan XiaoJie, Yan HongQing. Observation of dietary intervention on nutritional risk in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(8): 764-767. doi: 10.3969/j.issn.1001-5256.2014.08.016
[19]	Wang MaoRong. Paying attention to nutritional management of hepatic encephalopathy in patients with liver cirrhosis: introduction to ISHEN consensus[J]. Journal of Clinical Hepatology, 2013, 29(9): 649-651. doi: 10.3969/j.issn.1001-5256.2013.09.004

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	严兆兰. 青海地区乙型肝炎肝硬化并发轻微肝性脑病Stroop测试及诱发疾病危险因素调查分析. 中华养生保健. 2024(22): 84-86 .
2.	符健，高艺，林锋，李盼盼. 海口地区轻微肝性脑病PHES标准参考值范围的研究. 海南医学. 2023(13): 1903-1907 .
3.	樊亚楠，纪童童，梁荣月，于岩岩，徐京杭. 肝硬化合并显性肝性脑病危险因素的回顾性分析：一项单中心病例对照研究. 中华肝脏病杂志. 2021(02): 133-136 .
4.	边倩，解新科，寇小妮，李京涛，魏海梁，闫曙光. 通腑降浊汤联合乳果糖治疗热扰心神型肝性脑病临床观察. 山东中医杂志. 2021(06): 577-582 .
5.	覃秀容，陈月桥，石清兰，毛德文. 轻微肝性脑病的中西医研究进展. 中医药导报. 2020(12): 152-156 .
6.	王琳. 疏肝解郁胶囊治疗伴抑郁焦虑的肝性脑病患者的效果. 国际精神病学杂志. 2019(05): 925-928 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(6)

Get Citation

PDF

XML

Article Metrics

Article views (736) PDF downloads(97)

Value of lactate level in predicting the short-term prognosis of patients with acute-on-chronic hepatitis B liver failure

DOI: 10.3969/j.issn.1001-5256.2022.07.007

Abstract

References

Relative Articles

Cited by

Periodical cited type(6)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content